Sonrotoclax for myelodysplastic-myeloproliferative diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Feb 2021: Trial registered, NCT04771130
  2. 24 May 2021: Trial started, NCT04771130

The trials

NCT04771130: A Study of BGB-11417 in Participants With Myeloid Malignancies

State
Under way
Phase
Phase 1 and Phase 2
People
260 planned
Started
24 May 2021
Primary completion
31 Aug 2028
Arms
Part 3: AML and MDS Cohort
Results
None posted
  1. 25 Feb 2021: Trial registered
  2. 24 May 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Beqalzi.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.